Kopitz C - Search Results

1

Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.

Kopitz C, Gerg M, Bandapalli OR, Ister D, Pennington CJ, Hauser S, Flechsig C, Krell HW, Antolovic D, Brew K, Nagase H, Stangl M, von Weyhern CW, Brücher BL, Brand K, Coussens LM, Edwards DR, Krüger A. Kopitz C, et al. Cancer Res. 2007 Sep 15;67(18):8615-23. doi: 10.1158/0008-5472.CAN-07-0232. Cancer Res. 2007. PMID: 17875701 Free article.

2

Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model.

Arlt M, Kopitz C, Pennington C, Watson KL, Krell HW, Bode W, Gansbacher B, Khokha R, Edwards DR, Krüger A. Arlt M, et al. Among authors: kopitz c. Cancer Res. 2002 Oct 1;62(19):5543-50. Cancer Res. 2002. PMID: 12359766

3

Antimetastatic activity of a novel mechanism-based gelatinase inhibitor.

Krüger A, Arlt MJ, Gerg M, Kopitz C, Bernardo MM, Chang M, Mobashery S, Fridman R. Krüger A, et al. Among authors: kopitz c. Cancer Res. 2005 May 1;65(9):3523-6. doi: 10.1158/0008-5472.CAN-04-3570. Cancer Res. 2005. PMID: 15867341

4

Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the host.

Kopitz C, Anton M, Gansbacher B, Krüger A. Kopitz C, et al. Cancer Res. 2005 Oct 1;65(19):8608-12. doi: 10.1158/0008-5472.CAN-05-1572. Cancer Res. 2005. PMID: 16204025

5

Distinct functionality of tumor cell-derived gelatinases during formation of liver metastases.

Gerg M, Kopitz C, Schaten S, Tschukes A, Kahlert C, Stangl M, von Weyhern CW, Brücher BL, Edwards DR, Brand K, Krüger A. Gerg M, et al. Among authors: kopitz c. Mol Cancer Res. 2008 Mar;6(3):341-51. doi: 10.1158/1541-7786.MCR-07-2032. Mol Cancer Res. 2008. PMID: 18337444

6

Plasminogen activator inhibitor-2, but not cystatin C, inhibits the prometastatic activity of tissue inhibitor of metalloproteinases-1 in the liver.

Kopitz C, Gerg M, Gansbacher B, Krüger A. Kopitz C, et al. Hum Gene Ther. 2008 Oct;19(10):1039-49. doi: 10.1089/hum.2008.078. Hum Gene Ther. 2008. PMID: 18681831

7

Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.

Krüger A, Soeltl R, Sopov I, Kopitz C, Arlt M, Magdolen V, Harbeck N, Gänsbacher B, Schmitt M. Krüger A, et al. Among authors: kopitz c. Cancer Res. 2001 Feb 15;61(4):1272-5. Cancer Res. 2001. PMID: 11245418

8

Increase of anti-metastatic efficacy by selectivity- but not affinity-optimization of synthetic serine protease inhibitors.

Banke IJ, Arlt MJ, Pennington C, Kopitz C, Steinmetzer T, Schweinitz A, Gansbacher B, Quigley JP, Edwards DR, Stürzebecher J, Krüger A. Banke IJ, et al. Among authors: kopitz c. Biol Chem. 2003 Oct-Nov;384(10-11):1515-25. doi: 10.1515/BC.2003.168. Biol Chem. 2003. PMID: 14669995

9

Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis.

Elezkurtaj S, Kopitz C, Baker AH, Perez-Cantó A, Arlt MJ, Khokha R, Gansbacher B, Anton M, Brand K, Krüger A. Elezkurtaj S, et al. Among authors: kopitz c. J Gene Med. 2004 Nov;6(11):1228-37. doi: 10.1002/jgm.637. J Gene Med. 2004. PMID: 15390257

10

Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by host-derived urokinase-type plasminogen activator.

Schrötzlmair F, Kopitz C, Halbgewachs B, Lu F, Algül H, Brünner N, Gänsbacher B, Krüger A. Schrötzlmair F, et al. Among authors: kopitz c. J Cell Mol Med. 2010 Dec;14(12):2760-70. doi: 10.1111/j.1582-4934.2009.00951.x. J Cell Mol Med. 2010. PMID: 19863693 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page